PET/CT for Planning and Monitoring of Targeted Radiotherapy
Edition 7/12 of PET and MoRe Webinar Series

Brief summary of contents

This webinar deals with the use of PET/CT for planning and monitoring of radionuclide therapy. In this we will describe the use of PET/CT for patient selection, dosimetry (pre- and post-therapy) as well as response evaluation of radionuclide therapy. After a discussion of theoretical aspects these will then be illustrated by 5 representative cases.

Content: Presentation and MCQ test (10 questions)
Length: 38:25 min



View
(5)
PET/MRI imaging in prostate cancer

Edition 6/12 of PET and MoRe Webinar Series

Learning objectives:

-         Introduce the students to new hybrid imaging techniques and their applications in clinical routine

-         Provide the basic guidelines for imaging protocols of specific studies

-         Provide selected teaching cases

-         Review the basics of image interpretation of hybrid PET-MR studies

-         Initiate the basic discussions on advantages and potential limitations of hybrid PET-MR compared to separate modalities



Content: Presentation and MCQ test (10 questions)
Length: 24:13

View
(3)
PET/CT for lymphoma
Edition 5/12 of PET and MoRe Webinar Series


Learning objectives:

The objective of the webinar is to provide knowledge about lymphoproliferative diseases, which include a wide range of malignant diseases with various histological characteristics, clinical presentation and therapeutic possibilities. 18F-FDG –PET/CT is essential imaging method which contributes to the assessment of the spread of the disease, provides prognostic information and represents a useful method to monitor the treatment benefits in lymphoma. All these aspects of the method utilization are explained.

Content: Presentation and MCQ test (5 questions)
Length: 51:43

View
(4)
PET/CT for lung cancer and the use in Radiation Therapy
Edition 4/12 of PET and MoRe Webinar Series

Learning Objectives:
to better understand the context of the use of PET for radiotherapy planning in lung cancer.

Short Description:
this webinar highlights actual topics in the context of the use of PET in radiotherapy for lung cancer.

Content: Presentation and MCQ test (5 question)
Length: 45:25

View
(3)
PET/CT For RTP In Head And Neck
Edition 3/12 of PET and MoRe Webinar Series

FDG PET/CT has an increasing role in the diagnosis and staging of cancer in the head and neck. As a next step, the FDG PET images can be incorporated in the tumour delineation phase of radiotherapy treatment planning (RTP). This application requires some specific adaptations of PET imaging and interpretation. This Webinar aims to explain the methodology and clinical impact of PET/CT in the RTP process.

Content: Presentation and MCQ test (6 questions)
Length: 35:14

View
(1)
PET/CT for Neurodegenerative Diseases
Edition 2/12 of PET and MoRe Webinar Series

An introduction on the brain 18F-FDG PET procedure and the diagnostic role of 18F-FDG PET in neurodegenerative disorders, the webinar will focus of the description of several 18F-FDG PET patterns characteristic of the main neurodegenerative disorders, including dementias and parkinsonisms. A clinical cases demonstration with questions and answers will follow, in order to recap the main features of the 18F-FDG PET patterns and apply them to clinical practice.

Content: Presentation and MCQ test (6 questions)
Length: 37:33min

View
(5)
PET/MRI Breast Imaging
Edition 1/12 of PET and MoRe Webinar Series

Learning objectives:

MRI is sensitive, with insufficient specificity:
- Preoperative MRI is very sensitive yet may have false-positive findings leading to unnecessary biopsies
- Combining Molecular PET imaging with anatomical and functional MRI
- Increase specificity
- Decrease unnecessary biopsies
- Confirmation of targeted lesion being biopsied
- Improved evaluation of posterior lesions, chest wall and lymph node involvement


Content: Presentation and MCQ test (6 questions)
Length: 43:08 min

View
(2)